| | | | |

Mesothelioma Staging: Laparoscopy May Find Tumors PET-CT Misses

mesothelioma staging

Cancer researchers at Baylor College of Medicine say diagnostic laparoscopy (DL) improves the accuracy of pleural mesothelioma staging prior to surgery. It is especially valuable for patients with cancer in both the chest and abdomen.

Staging is a way for doctors to determine how widespread cancer is. Accurate staging is critical for the best surgical outcomes. For the right patients, mesothelioma surgery can be a life saver. 

Many mesothelioma patients undergo PET/CT as part of the staging process. But the Baylor study suggests that adding a tool called a laparoscope to the process may find tumors that PET-CT misses.

What is Mesothelioma Staging?

Malignant mesothelioma is a type of cancer that grows on internal membranes. It usually occurs on the membrane around the lungs, which is called the pleura. Pleural mesothelioma can spread onto the peritoneal membrane in the abdomen, too. Treatment decisions often depend on how far the cancer has spread. This is called mesothelioma staging.  

There are four main stages of mesothelioma. In Stage 1, the tumor has not grown deeply into the surrounding tissue. In Stages 2 and 3, there is more mesothelioma in the tissue surrounding the original tumor. Some mesothelioma cells may be in the lymph nodes. 

Stage 4 or advanced mesothelioma is in the lymph nodes and has spread to other parts of the body. Accurate mesothelioma staging is especially important for planning surgery. Surgeons are more likely to have success removing a tumor that is more confined.

Tools for Assessing Cancer Stage

The Baylor study included 187 mesothelioma patients. These patients had PET-CT scans or standard CT scans for mesothelioma staging. But they also had diagnostic laparoscopy. A laparoscope is a camera attached to a thin tube. It lets doctors look inside the chest and abdomen through a small incision. 

In 17 percent of the patients, diagnostic laparoscopy revealed that they had mesothelioma in their abdomen as well as their chest. This hardly ever showed up on their imaging scans. PET-CT scans correctly found peritoneal spread only 23 percent of the time. In 77 percent of cases, these patients had negative PET-CT scans for peritoneal disease. 

Overall, PET-CT was 68 percent accurate at finding peritoneal disease during mesothelioma staging. 

“PET-CT has low sensitivity and diagnostic accuracy to identify peritoneal disease in malignant pleural mesothelioma,” lead author R. Taylor Ripley explains. In an article in the Annals of Thoracic Surgery, Dr. Ripley and colleagues say diagnostic laparoscopy is more likely to find unexpected tumors in the abdomen.

“DL as part of pre-operative staging defines an important subset of patients with bicavitary disease,” Ripley concludes. The report recommends that mesothelioma surgeons make DL a routine part of mesothelioma staging before surgery. 

Source:

Ripley, RT, at al, “Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma with Routine PET Imaging”, December 2020, Annals of Thoracic Surgery, Online ahead of print, https://www.annalsthoracicsurgery.org/article/S0003-4975(20)32035-X/pdf

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…